Icodec

Phase IIIa trials reveal further positive outcomes of once-weekly insulin icodec in adults with type 2 diabetes

Positive Phase IIIa Results: Once-Weekly Insulin Icodec Benefits Adults with Type 2 Diabetes

SG Tylor

Source – Novo Nordisk Novo Nordisk, on June 25, 2023, released new findings from Phase IIIa trials, ONWARDS 1 and ...